サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1786432

心臓血管向けデジタルヘルスの世界市場

Digital Health for Cardiovascular

出版日
ページ情報
英文 282 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
心臓血管向けデジタルヘルスの世界市場
出版日: 2025年08月08日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 282 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心臓血管向けデジタルヘルスの世界市場は2030年までに1,193億米ドルに到達

2024年に419億米ドルと推定される心臓血管向けデジタルヘルスの世界市場は、2024年から2030年にかけてCAGR 19.1％で成長し、2030年には1,193億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるソフトウェアコンポーネントは、CAGR 17.0%を記録し、分析期間終了時には624億米ドルに達すると予測されます。ハードウェアコンポーネント分野の成長率は、分析期間中CAGR 22.1％と推定されます。

米国市場は114億米ドル、中国はCAGR 25.5％で成長予測

米国の心臓血管向けデジタルヘルス市場は、2024年に114億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに274億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは25.5%です。その他の注目すべき地域別市場としては、日本とカナダがあり、それぞれ分析期間中に15.4%と16.9%のCAGRで成長すると予測されています。欧州では、ドイツがCAGR約15.9%で成長すると予測されています。

世界の心臓血管向けデジタルヘルス市場- 主要動向と促進要因まとめ

AIと遠隔モニタリングは心血管疾患の負担を軽減できるか？

心血管ケアにおけるデジタルヘルスソリューションの統合は、人工知能（AI）、遠隔患者モニタリング（RPM）、ウェアラブル技術を活用して心血管の健康状態をリアルタイムで把握することで、心臓関連疾患の管理方法を再構築しています。心血管疾患（CVD）は依然として世界の死亡率の主要原因であり、継続的なモニタリングと早期介入戦略が必要です。AI主導のアルゴリズムは現在、心電図（ECG）を分析し、不整脈を検出し、潜在的な心疾患を事前に予測することができます。スマートウォッチや接続型ECGパッチなどの遠隔モニタリング・ソリューションにより、医師は患者が頻繁に病院を訪れることなく、心拍変動、血圧、不整脈を追跡することができます。AIを搭載したバーチャルアシスタントが台頭し、個人に合わせた推奨、服薬リマインダー、生活習慣の改善を提供することで、患者エンゲージメントがさらに向上しています。デジタル心血管系ソリューションは早期発見と疾病管理を強化する一方で、規制当局の承認、データプライバシーに関する懸念、償還政策などの課題が依然として普及の障壁となっています。しかし、AIと遠隔モニタリング技術が改善し続けるにつれて、よりプロアクティブで、データ駆動型で、アクセスしやすくなることで、心血管治療を変革する態勢が整っています。

デジタルセラピューティクス（DTx）はどのように心血管アウトカムを改善するのか？

デジタルセラピューティクス（DTx）は、従来の治療を補完するエビデンスに基づいたソフトウェア主導の介入を提供し、心血管疾患管理における強力なツールとして台頭してきています。一般的なウェルネス・アプリとは異なり、DTxソリューションは臨床的に検証され、高血圧、高コレステロール、肥満などの特定の心血管危険因子をターゲットとして設計されています。Omada HealthやLivongoのような企業は、行動修正戦略を通じて患者が生活習慣関連のリスク因子を管理するのを支援する、AIを活用したデジタル・コーチング・プログラムを開発しています。さらに、継続的モニタリング機器と統合されたデジタル治療薬は、リアルタイムの警告と介入勧告を提供し、急性心イベントのリスクを低減します。バリューベースのヘルスケアモデルへのシフトは、保険プロバイダーがデジタル治療薬をカバーする原動力にもなっており、こうしたソリューションが患者にとってより利用しやすくなっています。しかし、規制上の課題、医師による採用のためらい、長期的な臨床検証の必要性などが、心血管系医療におけるDTxソリューションの拡大には依然として障害となっています。調査によってその有効性が実証され続けるにつれて、デジタル治療薬は心血管疾患の予防と管理の中核的要素になると期待されています。

個別化された心血管治療においてAIとビッグデータが果たす役割とは？

AIとビッグデータ解析は、心血管治療計画の個別化においてますます重要な役割を果たしており、個人の遺伝的、代謝的、生活習慣的要因に基づく精密医療へのアプローチを可能にしています。機械学習モデルは、電子カルテ（EHR）、遺伝子マーカー、患者報告データなどの膨大なデータセットを分析し、心血管患者の個別化治療経路を特定するために使用されています。AI主導のリスク予測モデルは、心臓病発症の可能性に基づいて患者を層別化し、早期介入と的を絞った予防措置を可能にします。さらに、AIを搭載したチャットボットと遠隔医療プラットフォームは、オーダーメイドの推奨を提供し、心血管健康に関する問い合わせにリアルタイムで回答することで、患者エンゲージメントを向上させています。膨大な可能性があるにもかかわらず、心血管ヘルスケアにおけるAIの能力を最大限に引き出すためには、AIモデルの偏り、データの相互運用性の問題、規制当局の承認の必要性などの課題に対処しなければならないです。しかし、ビッグデータが精密医療のアプローチを洗練し続けるにつれて、AIは心血管治療の転帰を最適化する上で不可欠な役割を果たすと期待されています。

心臓血管向けデジタルヘルス市場の成長の原動力は？

心臓血管向けデジタルヘルス市場の成長は、心臓疾患の有病率の増加、ウェアラブルヘルス技術の採用の増加、AI主導型診断の進歩など、いくつかの要因によってもたらされます。遠隔医療サービスへの世界のシフトにより、遠隔患者モニタリングや在宅心臓ケアの需要が急増しています。規制機関もデジタルヘルス介入の重要性を認識しており、デジタル心血管系ソリューションの承認と償還サポートの増加に繋がっています。ブロックチェーンとサイバーセキュリティ対策の統合は、患者データのセキュリティを強化し、デジタルヘルスプラットフォームへの信頼を高めています。さらに、精密医療と個別化治療アプローチの台頭が、ヘルスケアプロバイダーを心血管治療におけるAIを活用した予測分析へと押し上げています。デジタルヘルス新興企業への継続的な投資と、ハイテク企業、ヘルスケアプロバイダー、保険会社間の戦略的提携により、デジタル心血管系健康市場は大きな成長を遂げ、心臓病管理の未来を再構築することになります。

セグメント

コンポーネント（ソフトウェアコンポーネント、ハードウェアコンポーネント、サービス・コンポーネント）;最終用途（患者、プロバイダー、支払者、その他）

調査対象企業の例

  • AliveCor
  • Amwell
  • Cardiogram
  • CardioSignal
  • Cardiovascular Health Solutions
  • Cleerly
  • DarioHealth
  • Eko
  • Fitbit
  • HeartFlow
  • Hello Heart
  • Idoven
  • Lark Health
  • Medtronic
  • Omron Healthcare
  • Philips Healthcare
  • Withings
  • Neko Health
  • Story Health
  • WellDoc

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP30497

Global Digital Health for Cardiovascular Market to Reach US$119.3 Billion by 2030

The global market for Digital Health for Cardiovascular estimated at US$41.9 Billion in the year 2024, is expected to reach US$119.3 Billion by 2030, growing at a CAGR of 19.1% over the analysis period 2024-2030. Software Component, one of the segments analyzed in the report, is expected to record a 17.0% CAGR and reach US$62.4 Billion by the end of the analysis period. Growth in the Hardware Component segment is estimated at 22.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$11.4 Billion While China is Forecast to Grow at 25.5% CAGR

The Digital Health for Cardiovascular market in the U.S. is estimated at US$11.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$27.4 Billion by the year 2030 trailing a CAGR of 25.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.4% and 16.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.9% CAGR.

Global Digital Health for Cardiovascular Market - Key Trends & Drivers Summarized

Can AI and Remote Monitoring Reduce Cardiovascular Disease Burden?

The integration of digital health solutions in cardiovascular care is reshaping how heart-related diseases are managed, leveraging artificial intelligence (AI), remote patient monitoring (RPM), and wearable technologies to provide real-time insights into cardiovascular health. Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, necessitating continuous monitoring and early intervention strategies. AI-driven algorithms are now capable of analyzing electrocardiograms (ECGs), detecting arrhythmias, and predicting potential cardiac events before they occur. Remote monitoring solutions, such as smartwatches and connected ECG patches, allow physicians to track heart rate variability, blood pressure, and irregular heart rhythms without requiring patients to visit hospitals frequently. The rise of AI-powered virtual health assistants is further improving patient engagement by offering personalized recommendations, medication reminders, and lifestyle modifications. While digital cardiovascular solutions enhance early detection and disease management, challenges such as regulatory approval, data privacy concerns, and reimbursement policies remain barriers to widespread adoption. However, as AI and remote monitoring technologies continue to improve, they are poised to transform cardiovascular care by making it more proactive, data-driven, and accessible.

How Are Digital Therapeutics (DTx) Improving Cardiovascular Outcomes?

Digital therapeutics (DTx) are emerging as a powerful tool in cardiovascular disease management, offering evidence-based, software-driven interventions to complement traditional treatments. Unlike general wellness apps, DTx solutions are clinically validated and designed to target specific cardiovascular risk factors such as hypertension, high cholesterol, and obesity. Companies like Omada Health and Livongo are developing AI-powered digital coaching programs that help patients manage lifestyle-related risk factors through behavior modification strategies. Furthermore, digital therapeutics integrated with continuous monitoring devices provide real-time alerts and intervention recommendations, reducing the risk of acute cardiac events. The shift toward value-based healthcare models is also driving insurance providers to cover digital therapeutics, making these solutions more accessible to patients. However, regulatory challenges, physician adoption hesitancy, and the need for long-term clinical validation remain obstacles to scaling DTx solutions in cardiovascular health. As research continues to demonstrate their effectiveness, digital therapeutics are expected to become a core component of cardiovascular disease prevention and management.

What Role Do AI and Big Data Play in Personalized Cardiovascular Care?

AI and big data analytics are playing an increasingly critical role in personalizing cardiovascular treatment plans, allowing for precision medicine approaches based on an individual's genetic, metabolic, and lifestyle factors. Machine learning models are being used to analyze vast datasets, including electronic health records (EHRs), genetic markers, and patient-reported data, to identify personalized treatment pathways for cardiovascular patients. AI-driven risk prediction models can stratify patients based on their likelihood of developing heart disease, enabling early intervention and targeted preventive measures. Additionally, AI-powered chatbots and telehealth platforms are improving patient engagement by providing tailored recommendations and answering cardiovascular health queries in real time. Despite the immense potential, challenges such as bias in AI models, data interoperability issues, and the need for regulatory approvals must be addressed to unlock the full capabilities of AI in cardiovascular healthcare. However, as big data continues to refine precision medicine approaches, AI is expected to play an indispensable role in optimizing cardiovascular treatment outcomes.

What Is Driving the Growth of the Digital Health for Cardiovascular Market?

The growth in the digital health for cardiovascular market is driven by several factors, including the increasing prevalence of heart diseases, rising adoption of wearable health technologies, and advancements in AI-driven diagnostics. The demand for remote patient monitoring and home-based cardiac care is surging due to the global shift toward telehealth services. Regulatory bodies are also recognizing the importance of digital health interventions, leading to increased approvals and reimbursement support for digital cardiovascular solutions. The integration of blockchain and cybersecurity measures is enhancing patient data security, increasing trust in digital health platforms. Additionally, the rise of precision medicine and personalized treatment approaches is pushing healthcare providers toward AI-powered predictive analytics in cardiovascular care. With continued investment in digital health startups and strategic partnerships among tech companies, healthcare providers, and insurers, the digital cardiovascular health market is set to experience significant growth, reshaping the future of heart disease management.

SCOPE OF STUDY:

The report analyzes the Digital Health for Cardiovascular market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Software Component, Hardware Component, Service Component); End-Use (Patients End-Use, Providers End-Use, Payers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • AliveCor
  • Amwell
  • Cardiogram
  • CardioSignal
  • Cardiovascular Health Solutions
  • Cleerly
  • DarioHealth
  • Eko
  • Fitbit
  • HeartFlow
  • Hello Heart
  • Idoven
  • Lark Health
  • Medtronic
  • Omron Healthcare
  • Philips Healthcare
  • Withings
  • Neko Health
  • Story Health
  • WellDoc

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Digital Health for Cardiovascular - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Cardiovascular Diseases Drives Demand for Digital Health Solutions in Cardiovascular Care
    • Surge in Remote Patient Monitoring and Telemedicine Adoption Expands Addressable Market for Cardiovascular Digital Health Technologies
    • Technological Advancements in Wearable Devices and Health Monitoring Tools Strengthen the Business Case for Digital Health in Cardiovascular Care
    • Growing Consumer Awareness of Heart Health Accelerates Adoption of Digital Health Solutions for Cardiovascular Disease Prevention
    • Rising Healthcare Costs and Need for Efficient Treatment Models Propel Demand for Digital Health Solutions in Cardiovascular Disease Management
    • Integration of Artificial Intelligence and Machine Learning in Cardiovascular Digital Health Tools Enhances Diagnosis and Treatment Planning
    • Increased Focus on Personalized Healthcare and Precision Medicine Drives Growth in Digital Health Solutions Tailored for Cardiovascular Patients
    • Expansion of Mobile Health Applications and Smartphone Integration Strengthens the Market for Cardiovascular Health Management Tools
    • The Proliferation of Big Data and Predictive Analytics in Cardiovascular Care Accelerates Adoption of Digital Health Platforms for Early Diagnosis
    • Surge in Investment by Governments and Healthcare Providers in Digital Health Infrastructure Drives Market Growth
    • The Integration of IoT in Cardiovascular Health Devices Enables Real-Time Data Collection, Expanding Market Opportunities
    • Regulatory Support for Digital Health Solutions and Remote Monitoring Devices Strengthens Market Confidence and Adoption
    • The Shift Toward Preventative Healthcare and Early Detection Strengthens Demand for Digital Health Solutions in Cardiovascular Care
    • Increasing Need for Chronic Disease Management Solutions Drives Growth in Digital Health Platforms for Long-Term Cardiovascular Care
    • Expansion of Healthcare Networks and Telehealth Programs Creates Opportunities for Cardiovascular Digital Health Solutions in Rural and Underserved Areas
    • The Growth of Cloud Computing and Data Storage Solutions in Healthcare Expands the Scalability and Reach of Digital Health Tools for Cardiovascular Care
    • The Rising Popularity of Fitness and Wellness Tracking Devices Drives Demand for Digital Health Solutions in Cardiovascular Health Management
    • Rising Incidence of Cardiovascular Disease in Aging Populations Expands the Addressable Market for Digital Cardiovascular Health Solutions
    • Regulatory Advances in Digital Health Technologies Create New Opportunities for Compliance-Driven Cardiovascular Health Solutions
    • Increased Focus on Patient Engagement and Empowerment Drives Adoption of Digital Health Tools for Cardiovascular Disease Prevention and Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Digital Health for Cardiovascular Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Digital Health for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Digital Health for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Software Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Hardware Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Service Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Service Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Service Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Patients End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Patients End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Patients End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Providers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Payers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Digital Health for Cardiovascular by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Digital Health for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Digital Health for Cardiovascular by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Digital Health for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Digital Health for Cardiovascular by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Digital Health for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Digital Health for Cardiovascular by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Digital Health for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION